Cargando…

Prognostic value of MET copy number gain in non-small-cell lung cancer: an updated meta-analysis

The alterations of MET have been detected in non-small-cell lung cancer (NSCLC). However, the prognostic impact of MET gene copy number gain (CNG) has not been consistent among studies. We performed this meta-analysis to evaluate the prognostic value of high MET CNG in patients with NSCLC. A systema...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Jung Han, Kim, Hyeong Su, Kim, Bum Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5968772/ https://www.ncbi.nlm.nih.gov/pubmed/29805710 http://dx.doi.org/10.7150/jca.24980

Ejemplares similares

Prognostic value of c-Met overexpression in pancreatic adenocarcinoma: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic value of MET, cyclin D1 and MET gene copy number in non-small cell lung cancer
por: Sun, Wenze, et al.
Publicado: (2013)

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

MET inhibitors in advanced non-small-cell lung cancer: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas
por: Seo, A N, et al.
Publicado: (2014)

Prognostic value of smoking status in non-small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic value of KRAS mutation in advanced non-small-cell lung cancer treated with immune checkpoint inhibitors: A meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

c-MYC Copy-Number Gain Is an Independent Prognostic Factor in Patients with Colorectal Cancer
por: Lee, Kyu Sang, et al.
Publicado: (2015)

Prognostic impact of high c-Met expression in ovarian cancer: a meta-analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

MET Expression Level in Lung Adenocarcinoma Loosely Correlates with MET Copy Number Gain/Amplification and Is a Poor Predictor of Patient Outcome
por: Yin, Wei, et al.
Publicado: (2022)

Prognostic Value of MET Gene Copy Number and Protein Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Published Literatures
por: Guo, Baoping, et al.
Publicado: (2014)

Clinicopathological impacts of high c-Met expression in renal cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

ALK gene copy number gains in non-small-cell lung cancer: prognostic impact and clinico-pathological correlations
por: Peretti, U., et al.
Publicado: (2016)

Clinicopathological impacts of high c-Met expression in head and neck squamous cell carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Relationships between Chromosome 7 Gain, MET Gene Copy Number Increase and MET Protein Overexpression in Chinese Papillary Renal Cell Carcinoma Patients
por: Yin, Xiaolu, et al.
Publicado: (2015)

Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis
por: Kim, Jung Han, et al.
Publicado: (2018)

MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC)
por: Casadevall, David, et al.
Publicado: (2015)

Prognostic Value of Germline Copy Number Variants and Environmental Exposures in Non-small Cell Lung Cancer
por: Chen, Shizhen, et al.
Publicado: (2021)

Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC
por: Zito Marino, Federica, et al.
Publicado: (2020)

MET expression and copy number status in clear-cell renal cell carcinoma: prognostic value and potential predictive marker
por: Macher-Goeppinger, Stephan, et al.
Publicado: (2016)

Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2017)

Anaplastic Lymphoma Kinase Gene Copy Number Gain in Inflammatory Breast Cancer (IBC): Prevalence, Clinicopathologic Features and Prognostic Implication
por: Kim, Min Hwan, et al.
Publicado: (2015)

Survival benefit of immune checkpoint inhibitors according to the histology in non-small-cell lung cancer: A meta-analysis and review
por: Kim, Bum Jun, et al.
Publicado: (2017)

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome
por: Lee, H E, et al.
Publicado: (2012)

High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy
por: Wu, Shibo, et al.
Publicado: (2020)

The prognostic significance of MCL1 copy number gain in esophageal squamous cell carcinoma
por: Xu, Chen, et al.
Publicado: (2017)

Prognostic and predictive values of EGFR overexpression and EGFR copy number alteration in HER2-positive breast cancer
por: Lee, H J, et al.
Publicado: (2015)

Prognostic Values of Gene Copy Number Alterations in Prostate Cancer
por: Alfahed, Abdulaziz, et al.
Publicado: (2023)

Top-level MET gene copy number gain defines a subtype of poorly differentiated pulmonary adenocarcinomas with poor prognosis
por: Overbeck, Tobias Raphael, et al.
Publicado: (2020)

Clinical Significance of MET Gene Copy Number in Patients with Curatively Resected Gastric Cancer
por: Kang, Byung Woog, et al.
Publicado: (2015)

MET Gene Copy Number Predicts Worse Overall Survival in Patients with Non-Small Cell Lung Cancer (NSCLC); A Systematic Review and Meta-Analysis
por: Dimou, Anastasios, et al.
Publicado: (2014)

Centromere 17 copy number gain reflects chromosomal instability in breast cancer
por: Lee, Kyoungyul, et al.
Publicado: (2019)

c-myc copy number gain is a powerful prognosticator of disease outcome in cervical dysplasia
por: Kübler, Kirsten, et al.
Publicado: (2014)

Increased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non–Small Cell Lung Cancer()
por: Kowalczuk, Oksana, et al.
Publicado: (2014)

The addition of bevacizumab in the first-line treatment for metastatic colorectal cancer: an updated meta-analysis of randomized trials
por: Jang, Hyun Joo, et al.
Publicado: (2017)

Overexpression of MAPK15 in gastric cancer is associated with copy number gain and contributes to the stability of c-Jun
por: Jin, Dong-Hao, et al.
Publicado: (2015)

Clinical significance of PD-L1 and PD-L2 copy number gains in non-small-cell lung cancer
por: Inoue, Yusuke, et al.
Publicado: (2016)

Expression and copy number gains of the RET gene in 631 early and mid stage non‐small cell lung cancer cases
por: Tan, Ling, et al.
Publicado: (2018)

Clinical impacts of genomic copy number gains at Xq28
por: Yamamoto, Toshiyuki, et al.
Publicado: (2014)

Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration Model
por: Wang, Dingyuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_btg73fcibaushenh6egbkg62rp